PREVIEW #ESMO26 — pre-conference KOL intelligence for the ESMO Congress 2026 in Madrid, Oct 23–27 See the Preview →
KOL Pulse AI · #AILCC26 Post-Conference Edition · Conference Intelligence
All-Ireland Lung Cancer Conference 2026: Virtual Attendee Network
Post-conference edition, data through October 19, 2026. 54 accounts classified from 32 curated posts from All-Ireland Lung Cancer Conference 2026 (12th All-Ireland Lung Cancer Conference · Johnstown House Hotel, Enfield, Co. Meath, Ireland · October 16–17, 2026). Use it to follow up with the people who were in the room: click any of the top 5 KOLs to see exactly who amplified them - by category, region and country - and use the trial section to find the physicians who engaged with each trial during the meeting. The classification separates physicians, patient advocates and advocacy organizations, conference organizations, industry, and media. Pairs with the All-Ireland Lung Cancer Conference 2026 influencer network for who drove and who amplified the conversation.
44 Identified Accounts 3 Verified US Physicians 18 Int'l Physicians 9 Countries
Interactive Retweeter Analysis
Click any KOL below to explore their retweeter network
See who amplified each top voice — broken down by category, region, and country. The donut charts and Top 30 grid update in real time as you switch KOLs.
↓
Top 5 KOLs ranked by total impressions
Category Breakdown
All Physicians by Region
Top Accounts
Free Access · KOL Pulse Intelligence

Track oncology’s top KOLs in your specialty

Create a free account, pick the tumor types you cover, and go beyond the tweet — the intelligence pharma teams use to map influence and prepare for engagement:

  • ✓Enhanced KOL profiles
  • ✓Pharma influence & potential advisory-board patterns
  • ✓2025 Open Payments financial analysis
  • ✓Social-media sentiment & trend signals
Get free access — pick your specialty
Choose the tumor types you follow. No cost, unsubscribe anytime.
Trial Interest
Which Trials Were Physicians Engaged With at the All-Ireland Lung Cancer Conference 2026?
Physicians whose #AILCC26 posts or shared slides reference each trial - the conversations that formed in the room.
NHS-Galleri7 physiciansStephen V Liu · Jarushka Naidoo · Alfredo Addeo MD · Patrick Forde · Solange Peters · Yu Yang Soon · Cristina Zannori
DeLLphi-3046 physiciansStephen V Liu · Jarushka Naidoo · Gerry Hanna · Patrick Forde · Solange Peters · Dr NAVDEEP SINGH DM ( AIIMS ) New Delhi
DeLLphi-3086 physiciansStephen V Liu · Jarushka Naidoo · Gerry Hanna · Patrick Forde · Solange Peters · Dr NAVDEEP SINGH DM ( AIIMS ) New Delhi
HALT6 physiciansStephen V Liu · Jarushka Naidoo · Alfredo Addeo MD · Gerry Hanna · Solange Peters · Jennifer A. Marks
NORTHSTAR6 physiciansStephen V Liu · Jarushka Naidoo · Alfredo Addeo MD · Gerry Hanna · Solange Peters · Jennifer A. Marks
TAISHAN-3026 physiciansStephen V Liu · Jarushka Naidoo · Gerry Hanna · Patrick Forde · Solange Peters · Dr NAVDEEP SINGH DM ( AIIMS ) New Delhi
AEGEAN4 physiciansStephen V Liu · Patrick Forde · Solange Peters · Dr Celestino Gutiérrez González MD 🇪🇸🍏🇻🇪
CheckMate 77T4 physiciansStephen V Liu · Patrick Forde · Solange Peters · Dr Celestino Gutiérrez González MD 🇪🇸🍏🇻🇪
CheckMate 8164 physiciansStephen V Liu · Patrick Forde · Solange Peters · Dr Celestino Gutiérrez González MD 🇪🇸🍏🇻🇪
ELIOS4 physiciansStephen V Liu · Jarushka Naidoo · Solange Peters · Hazel O'Sullivan
KEYNOTE-6714 physiciansStephen V Liu · Patrick Forde · Solange Peters · Dr Celestino Gutiérrez González MD 🇪🇸🍏🇻🇪
NeoTORCH4 physiciansStephen V Liu · Patrick Forde · Solange Peters · Dr Celestino Gutiérrez González MD 🇪🇸🍏🇻🇪
RATIONALE-3154 physiciansStephen V Liu · Patrick Forde · Solange Peters · Dr Celestino Gutiérrez González MD 🇪🇸🍏🇻🇪
FLAURA2 physiciansStephen V Liu · Jennifer A. Marks
FLAURA22 physiciansStephen V Liu · Jennifer A. Marks
MARIPOSA2 physiciansStephen V Liu · Jennifer A. Marks
Understanding This Report
Questions This Report Answers

What does this data show?

A verified, classified map of the #AILCC26 conversation: 54 accounts from curated posts, including 21 physicians — 3 US physicians and 18 international colleagues from 9 countries (Ireland, Switzerland, Spain, UK lead). Institutional clusters are visible in the conference conversation: Geneva University Hospitals (HUG) (2), MedStar Georgetown University Hospital / Georgetown Lombardi (1), Cancer Centre Ireland (Beaumont RCSI) (1), St Luke's Radiation Oncology Network (1). Trial interest concentrates around NHS-Galleri (7 physicians), DeLLphi-304 (6 physicians), DeLLphi-308 (6 physicians). 1 patient advocates and advocacy organizations are active in the same conversation — and the bot and persona accounts that inflate raw follower metrics were identified and quarantined, so every physician here is bio-verified.

How can a KOL learn from this report?

Benchmark your own #AILCC26 presence against the 21 physicians mapped here: are your trials of interest among the crowded conversations (NHS-Galleri, DeLLphi-304, DeLLphi-308) or the quiet ones where a single voice still stands out? The category and region breakdowns show which patient advocacy voices and international colleagues were active in your space, and the trial section names the physicians - with their institutions - engaged with each trial, colleagues who were in the room at Johnstown House, Enfield

What does a worked example of using this data look like?

An MSL following up after the All-Ireland Lung Cancer Conference 2026: Geneva University Hospitals (HUG) alone had 2 physicians in the #AILCC26 conversation. Cross-reference the trial section — NHS-Galleri (7 physicians), DeLLphi-304 (6 physicians), DeLLphi-308 (6 physicians) are the crowded conversations — and the follow-up plan writes itself: which physicians at which institutions engaged with which trials during the meeting, before a single follow-up is booked. A KOL can run the same play in reverse: find your institution's cluster, see which trials your colleagues converged on, and position your own commentary where the map shows white space.

How can medical affairs and pharma teams use this report?

As post-meeting follow-up planning grounded in this page's own numbers: the category and region breakdowns surface the 3 verified US physicians and their international colleagues, each with institution and trial interests; the classification keeps engagement lists clean by separating treating physicians from the 2 media accounts and industry voices; and the trial-interest chips let field teams match MSL briefings to the trials a physician already follows. KOL identification tells you who matters; mapping tells you how the community organizes around institutions and trials — which is what engagement sequencing actually needs. Influence-mapping practice guides note this also reduces redundant outreach: teams see who is already saturated and who is unengaged.

Why is social influence mapping important in oncology?

Oncology standards change with each congress readout, and physicians increasingly learn about readouts from each other online — surveys report over 70% of HCPs use digital channels weekly for medical information, and in a LiveWorld–Sermo survey of 206 US physicians, 41% said social media influences prescribing behavior. A conference map matters because meeting days are when oncology opinion forms: this dataset shows the communities that organized around the All-Ireland Lung Cancer Conference 2026 — Geneva University Hospitals (HUG) and MedStar Georgetown University Hospital / Georgetown Lombardi clusters, 1 active patient advocacy organizations, and NHS-Galleri-focused physician groups.

What is the difference between a KOL and a Digital Opinion Leader?

A traditional KOL earns influence through trials, publications, and guideline work; a Digital Opinion Leader earns it through digital reach — posts, threads, podcasts, and amplification. Many physicians on this page are both: trial investigators whose conference posts reach tens of thousands. This report measures the digital half directly and pairs it with verified identity, institution, and trial interests so the two kinds of influence can be read together.

How can I use this report with my favorite AI tool?

This page is built to be read by AI assistants (ChatGPT, Gemini, Claude, Perplexity). Paste the URL into your tool and ask questions this page can actually answer: “Which institutions had the most physicians in the #AILCC26 conversation?”, “Which trials were All-Ireland Lung Cancer Conference 2026 physicians most engaged with?”, “Which physicians engaged with NHS-Galleri at the meeting?”, “List the patient advocacy organizations active around the All-Ireland Lung Cancer Conference 2026.” For who-influences-whom questions (a KOL’s amplifier network, which US physicians amplify a given voice), use the companion All-Ireland Lung Cancer Conference 2026 influencer network. Cite kolpulse.com when you share the answers.